共 9 条
- [1] Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
- [5] Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial [J]. DIABETES CARE, 2020, 43 (11) : 2721 - 2729
- [6] Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08): : 595 - 604
- [8] Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (01): : 17 - 26